[1]. J. Kurczewska, Materials Chemistry and Physics. 211, 34-41,(2018).
[2]. T. Yih, Journal of cellular biochemistry. 97, 1184-1190,(2006).
[3]. M. J. Mitchell, Nature Reviews Drug Discovery. 20, 101-124,(2021).
[4]. T. Dai, Biomaterials Science. 8, 3784-3799,(2020).
[5]. A. A. Yetisgin, Molecules (Basel, Switzerland). 25, 2193,(2020).
[6]. P. Chelle, Clinical Pharmacokinetics. 59, 245-256,(2020).
[7]. S. Marchesan, ACS Medicinal Chemistry Letters. 4, 147-149,(2013).
[8]. J. K. Patra, Journal of Nanobiotechnology. 16, 71, (2018)
[9]. M. M. Mohareri, Main Group Chemistry. Preprint, 1-11,(2021).
[10]. E. Alphandéry, Drug Discovery Today. 25, 141-149,(2020).
[11]. J.E. Kim, Archives of toxicology. 86, 685-700,(2012).
[12]. H.W. Yang, Nanotechnology, science and applications. 5, 73, (2012).
[13]. A. Gholami, Drug metabolism reviews. 52, 205-224,(2020).
[14]. O. Veiseh, Advanced drug delivery reviews. 62, 284-304,(2010).
[15]. W. Gao, Journal of drug targeting. 23, 619-626,(2015).
[16]. I. Lisiecki, Journal of the American Chemical Society. 115, 3887-3896, (1993).
[17]. X.H. Peng, International journal of nanomedicine. 3, 311,(2008).
[18]. K. Subramani, Current Nanoscience. 5, 135-140,(2009).
[19]. J. Frenkel, Nature. 126, 274-275,(1930).
[20]. M. Mahmoudi, Colloids and Surfaces B: Biointerfaces. 75, 300-309, (2010).
[21]. T. Osaka, Colloids and Surfaces B: Biointerfaces. 71, 325-330,(2009).
[22]. Q. Feng, Scientific reports. 8, 1-13,(2018).
[23]. M. A. Abakumov, Journal of biochemical and molecular toxicology. 32, 22225,(2018).
[24]. A. M. Predescu, Royal Society open science. 5, 171525,(2018).
[25]. S. Laurent, Chemical reviews. 108, 2064-2110,(2008).
[26]. S. A. M. K. Ansari, Materials. 12, 465,(2019).
[27]. Z. Gao, Advanced Science. 7, 1901624,(2020).
[28]. A. López-Cruz, Journal of Materials Chemistry. 19, 6870-6876, (2009).
[29]. I. Hilger, Academic radiology. 9, 198-202,(2002).
[30]. L. Babes, Journal of colloid and interface science. 212, 474-482,(1999).
[31]. H. Wei, Proceedings of the national academy of sciences. 114, 2325-2330,(2017).
[32]. K. J. Widder, Advances in Pharmacology. 16, 213-271,(1979).
[33]. A. S. Garanina, Nanomedicine: Nanotechnology, Biology and Medicine. 25, 102171,(2020).
[34]. C. Iacovita, Molecules. 21, 1357,(2016).
[35]. M. Freeman, Journal of Applied Physics. 31, S404-S405,(1960).
[36]. S. M. Moghimi, Pharmacological reviews. 53, 283-318,(2001).
[37]. S. Douglas, Critical reviews in therapeutic drug carrier systems. 3, 233-261,(1987).
[38]. S. M. Janib, Advanced drug delivery reviews. 62, 1052-1063,(2010).
[39]. M.M. Swidan, DARU Journal of Pharmaceutical Sciences. 27, 49-58,(2019).
[40]. E. Sattarzadeh, Journal of Radioanalytical and Nuclear Chemistry. 317, 1333-1339,(2018).
[41]. E. S. Khameneh, Radiochimica Acta. 106, 897-907,(2018).
[42]. Z. Pourmanouchehri, Journal of Inorganic and Organometallic Polymers and Materials. 28, 1980-1990,(2018).
[43]. S. Kakaei, Current Nanoscience. 16, 608-616,(2020).
[44]. H. Tayeri, International Journal of Radiation Research. 18, 235-241,(2020).
)
